Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study

Apr-25

Respiratory

AUTHORS : Adrien Coriat, Cegedim Group, 137 rue d’aguesseau, Boulogne-Billancourt, 92100, France Emai: adrien.coriat@cegedim.com

JOURNAL : Pubmed

REFERENCE:

DOI : 10.2147/COPD.S495086

Read more